Search Within

Raajit Kumar Rampal

Formats
  1. Meeting Abstract (191)
  2. Journal Article (123)
  3. Review (21)
  4. Research Letter (10)
  5. Book Section (2)
  6. Editorial (2)
  7. Guidelines (1)
  8. Miscellaneous (1)
Groups
  1. Adult Leukemia (351)
  2. Center for Hematologic Malignancies (351)
  3. Department of Medicine (351)
  4. Hematologic Malignancies, Division of (351)
  5. GSK Faculty (135)
  6. Executive Committee, Center for Hematologic Malignancies (131)

More Groups

People
  1. Ross Levine (87)
  2. Omar Abdel-Wahab (64)
  3. Martin Tallman (41)
  4. Eli Diamond (34)
  5. Ahmet Dogan (30)
  6. Minal Patel (29)

More People

Years
  1. 2025 (15)
  2. 2024 (35)
  3. 2023 (42)
  4. 2022 (36)
  5. 2021 (36)
  6. 2020 (26)

More Years

Publications
  1. Blood (148)
  2. Journal of Clinical Oncology (18)
  3. Blood Advances (15)
  4. Clinical Lymphoma, Myeloma and Leukemia (15)
  5. Haematologica (13)
  6. British Journal of Haematology (10)

More Publications

Publishers
  1. American Society of Hematology (164)
  2. Elsevier Inc. (24)
  3. Nature Publishing Group (22)
  4. American Society of Clinical Oncology (18)
  5. Ferrata Storti Foundation (13)
  6. American Association for Cancer Research (12)

More Publishers

Results (351)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Epo-IGF1R cross talk expands stress-specific progenitors in regenerative erythropoiesis and myeloproliferative neoplasm
    Journal Article

    Hsieh, H. H.; Yao, H.; Ma, Y.; Zhang, Y.; Xiao, X.; Stephens, H.; Wajahat, N.; Chung, S. S.; Xu, L.; Xu, J.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Hitting the brakes on accelerated and blast-phase myeloproliferative neoplasms: current and emerging concepts
    Review

    Bewersdorf, J. P.; Rampal, R. K.
    Hematology-American Society of Hematology Education Program (2022)

    Fulltext@MSK | Save
  • Krankheitsmodifizierendes potenzial von pelabresib, demonstriert durch verbesserung der knochenmarkfunktion und dem daraus resultierendem klinischen nutzen bei patienten mit myelofibrose
    Meeting Abstract

    Platzbecker, U.; Vannucchi, A.; Verstovsek, S.; Salama, M. E.; Mascarenhas, J.; Talpaz, M.; Mesa, R. A.; Rampal, R. K.; Oh, S. T.; Olteanu, H.; more...
    Oncology Research and Treatment (2022)

    Fulltext@MSK | Save
  • Pelabresib (CPI-0610) monotherapie in myelofibrose: Eine aktualisierung von klinischen und translationalen daten aus der laufenden MANIFEST studie
    Meeting Abstract

    Heidel, F.; Passamonti, F.; Kremyanskaya, M.; Mascarenhas, J.; Palandri, F.; Vannucchi, A. M.; Verstovsek, S.; Harrison, C.; Bose, P.; Schiller, G. J.; more...
    Oncology Research and Treatment (2022)

    Fulltext@MSK | Save
  • An open-label, multicenter, phase 1b/2 study of navtemadlin (KRT-232) in patients with relapsed/refractory acute myeloid leukemia secondary to myeloproliferative neoplasms
    Meeting Abstract

    Rampal, R.; Ramanathan, S.; Papayannidis, C.; von Bubnoff, N.; Díaz, M. D. T.; Vidriales, M. B.; Burguera, A. D. L. F.; Masarova, L.; Al-Ali, H. K.; Lavie, D.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Clinical characteristics and treatment outcomes in patients with histiocytic neoplasms harboring class 3 MAP2K1 mutations, including treatment with the ERK inhibitor ulixertinib
    Meeting Abstract

    Diamond, E. L.; Yabe, M.; Petrova-Drus, K.; Rosenblum, M.; Rotemberg, V.; Lacouture, M. E.; Rampal, R.; Francis, J.; Knoerzer, D.; Kreider, B.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Phase III MANIFEST-2: Pelabresib + ruxolitinib vs placebo + ruxolitinib in JAK inhibitor treatment-naive myelofibrosis
    Review

    Harrison, C. N.; Gupta, V. K.; Gerds, A. T.; Rampal, R.; Verstovsek, S.; Talpaz, M.; Kiladjian, J. J.; Mesa, R.; Kuykendall, A. T.; Vannucchi, A. M.; more...
    Future Oncology (2022)

    Fulltext@MSK | Save
  • HMGA1 chromatin regulators induce transcriptional networks involved in GATA2 and proliferation during MPN progression
    Journal Article

    Li, L.; Kim, J. H.; Lu, W.; Williams, D. M.; Kim, J.; Cope, L.; Rampal, R. K.; Koche, R. P.; Xian, L.; Luo, L. Z.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Retrospective analysis of pacritinib in patients with myelofibrosis and severe thrombocytopenia
    Journal Article

    Verstovsek, S.; Mesa, R.; Talpaz, M.; Kiladjian, J. J.; Harrison, C. N.; Oh, S. T.; Vannucchi, A. M.; Rampal, R.; Scott, B. L.; Buckley, S. A.; more...
    Haematologica (2022)

    Fulltext@MSK | Save
  • Cases in the management of polycythemia vera: The importance of strict hematocrit control
    Journal Article

    Rampal, R. K.
    Clinical Advances in Hematology & Oncology (2022)

    Fulltext@MSK | Save